ALC
HealthcareAlcon Inc.
$80.65
+$3.05 (+3.93%)
Jan 5, 2026
Price History (1Y)
Analysis
Alcon Inc. is a leading healthcare company operating in the Medical Instruments & Supplies industry within the Healthcare sector. The company boasts an impressive market capitalization of $39.77 billion and a substantial revenue stream of $10.18 billion (TTM). Alcon's large-scale operations are supported by its extensive workforce, comprising 25,000 employees. From a financial perspective, Alcon exhibits notable profitability metrics, including a gross margin of 55.6% and an operating margin of 12.9%. The company's returns on equity and assets stand at 4.8% and 2.6%, respectively, indicating moderate earnings growth potential. Alcon's balance sheet reveals a manageable debt-to-equity ratio of 23.72 and a substantial cash reserve of $1.50 billion, which is partially offset by debt of $5.24 billion. Valuation multiples for Alcon include a price-to-earnings ratio (TTM) of 36.83 and a forward P/E of 23.58. The company's revenue growth rate has been stable at 6.5% YoY, while earnings growth has seen a decline to -9.4%. Notably, Alcon offers a dividend yield of 43.0%, with a payout ratio of 16.2%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Alcon Inc.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Visit website →Key Statistics
- Market Cap
- $39.77B
- P/E Ratio
- 36.83
- 52-Week High
- $99.20
- 52-Week Low
- $71.55
- Avg Volume
- 1.90M
- Beta
- 0.69
- Dividend Yield
- 43.00%
Company Info
- Industry
- Medical Instruments & Supplies
- Exchange
- NYQ
- Country
- Switzerland
- Employees
- 25,000